Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025Program will feature ...
In the U.S., the number of ovarian cancer cases is predicted to be more than 20,000, and about 12,000 will die from it in ...
Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...
Each year, approximately 110,000 new cases of gynecologic cancers are diagnosed in the United States. In recognition of the ...
Since the 1970 s, studies have indicated that talc may be carcinogenic-- even studies conducted by one of its biggest ...
Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...
Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the immune system.
The scientists found some protein profiles showed much raised levels in individuals found to have breast, ovarian, prostate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback